Morning Stock Movers: Zoom, Robinhood Markets, BioNTech

The video discusses the financial performance of Zoom, highlighting its declining revenue growth rates and market reactions. It also covers potential SEC policy changes affecting Robinhood's business model, with implications for its stock. The biotech sector's response to CDC booster shot recommendations is examined, along with expectations for Crowdstrike's upcoming earnings report.

What was the impact of the SEC Commissioner's interview on Robinhood's shares?

What recommendation did the CDC advisory panel make regarding booster shots?